NEDA ZARRIN-KHAMEH
Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology HOUSTON, TX NPI 1467697607
Browse related groups: Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology TX Celgene Corporation All categories
General Payments — all program years on this page
$122.38
- Category: General Payments
- Program years: PY2018
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $122.38 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $122.38 | 8 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $67.61 | 4 |
| Exelixis Inc. | $27.15 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.25 | 1 |
| TAIHO ONCOLOGY, INC. | $13.37 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $122.38 | 8 |
Records — PY2018 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 537094043 | Bayer HealthCare Pharmaceuticals Inc. | $14.25 | 04/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 557677377 | Taiho Oncology, Inc. | $13.37 | 04/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 566902207 | Exelixis Inc. | $13.62 | 02/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 566902281 | Exelixis Inc. | $13.53 | 05/02/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 594927245 | Celgene Corporation | $16.55 | 01/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 595042997 | Celgene Corporation | $20.49 | 03/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 595165352 | Celgene Corporation | $16.85 | 06/14/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 595338301 | Celgene Corporation | $13.72 | 09/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.